Efficacy and safety of Echinaforce® in respiratory tract infections
- 20 December 2012
- journal article
- review article
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 163 (3-4) , 102-105
Abstract
Echinaforce® is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce®. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce® supports the immune resistance and acts directly against a series of viruses. Echinaforce® is efficacious and safe in respiratory tract infections for long-term and short-term prevention as well as for acute treatment. Echinaforce® ist der standardisierte Extrakt von Echinacea purpurea (Bioforce, Schweiz). Jüngste Studien zeigen eine Immunmodulation und breite antivirale Effekte gegen Atemwegsviren. Hä-magglutinin und Neuraminidase werden blockiert. Im Gegensatz zu Oseltamivir bewirkt Echinaforce® keine Resistenz. Eine randomisierte, plazbokontrollierte Doppelblindstudie über vier Monate bestätigt, dass Echinaforce® die Immunabwehr unterstützt und direkt gegen häufige Atemwegsviren wirkt. Echinaforce® ist bei Atemwegsinfekten effizient und sicher in der Langzeit- und Kurzzeit-Prävention, sowie in der Akutbehandlung.Keywords
This publication has 13 references indexed in Scilit:
- Safety and Efficacy Profile ofEchinacea purpureato Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled TrialEvidence-Based Complementary and Alternative Medicine, 2012
- Effects of Echinaforce® treatment on ex vivo-stimulated blood cellsPhytomedicine, 2011
- Editorial BoardSchweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, 2011
- Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)Virology Journal, 2009
- Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extractAntiviral Research, 2009
- Opportunistic infections as causes of death in HIV-infected patients in the HAART era in FranceScandinavian Journal of Infectious Diseases, 2005
- Picornavirus Infections: A Primer for the PractitionerArchives of Family Medicine, 2000
- Current estimates from the National Health Interview Survey, 1996.1999
- Problems and prospects of developing effective therapy for common cold virusesTrends in Microbiology, 1997
- Community study of role of viral infections in exacerbations of asthma in 9-11 year old childrenBMJ, 1995